These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6427304)

  • 1. Iron and gadolinium chelates as contrast agents in NMR imaging: preliminary studies.
    Carr DH; Brown J; Leung AW; Pennock JM
    J Comput Assist Tomogr; 1984 Jun; 8(3):385-9. PubMed ID: 6427304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies.
    Carr DH
    Physiol Chem Phys Med NMR; 1984; 16(2):137-44. PubMed ID: 6438657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of proton relaxation enhancers in magnetic resonance imaging.
    Carr DH
    Magn Reson Imaging; 1985; 3(1):17-25. PubMed ID: 3923290
    [No Abstract]   [Full Text] [Related]  

  • 4. Metal chelates as urographic contrast agents for magnetic resonance imaging. A comparative study.
    Marotti M; Schmiedl U; White D; Ramos E; Johnson T; Engelstad B
    Rofo; 1987 Jan; 146(1):89-93. PubMed ID: 3027795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic field dependence of solvent proton relaxation induced by Gd3+ and Mn2+ complexes.
    Koenig SH; Baglin C; Brown RD; Brewer CF
    Magn Reson Med; 1984 Dec; 1(4):496-501. PubMed ID: 6443784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
    Boehm-Sturm P; Haeckel A; Hauptmann R; Mueller S; Kuhl CK; Schellenberger EA
    Radiology; 2018 Feb; 286(2):537-546. PubMed ID: 28880786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular contrast agents suitable for magnetic resonance imaging.
    Runge VM; Clanton JA; Herzer WA; Gibbs SJ; Price AC; Partain CL; James AE
    Radiology; 1984 Oct; 153(1):171-6. PubMed ID: 6433402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency dependence of MR relaxation times. I. Paramagnetic ions.
    Vymazal J; Bulte JW; Frank JA; Di Chiro G; Brooks RA
    J Magn Reson Imaging; 1993; 3(4):637-40. PubMed ID: 8347957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue proton T1 and T2 response to gadolinium DTPA injection in rabbits. A potential renal contrast agent for NMR imaging.
    Wolf GL; Fobben ES
    Invest Radiol; 1984; 19(4):324-8. PubMed ID: 6090336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of membrane water permeability in characterization of pathologically altered human stomach tissues: NMR studies.
    Srejić R; Popov DV; Boricić I; Zuvela M
    Magn Reson Med; 1990 Sep; 15(3):469-74. PubMed ID: 2122170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast media in magnetic resonance tomography. A review. 1. Physicochemical and pharmacological bases of MR contrast media using gadolinium-DTPA as an example].
    Felix R; Semmler W; Schörner W; Laniado M
    Rofo; 1985 Jun; 142(6):641-6. PubMed ID: 2988062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2+ complexes of various polyaza macrocyclic ligands: implications for NMR imaging.
    Geraldes CF; Sherry AD; Brown RD; Koenig SH
    Magn Reson Med; 1986 Apr; 3(2):242-50. PubMed ID: 3086656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human testing of the nuclear spin tomographic contrast medium gadolinium-DTPA. Tolerance, contrast affect and the 1st clinical results].
    Schörner W; Felix R; Laniado M; Lange L; Weinmann HJ; Claussen C; Fiegler W; Speck U; Kazner E
    Rofo; 1984 May; 140(5):493-500. PubMed ID: 6429753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation: magnetic resonance of urography using a saturation inversion projection spin-echo sequence.
    Schad LR; Semmler W; Knopp MV; Deimling M; Weinmann HJ; Lorenz WJ
    Magn Reson Imaging; 1993; 11(3):319-27. PubMed ID: 8505865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of gadolinium-DTPA in the study of the urinary bladder].
    Beyer HK; Blümm R; Hötzinger H
    Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute and chronic cerebral infarctions: SPECT and gadolinium-DTPA enhanced MR imaging.
    Cordes M; Henkes H; Roll D; Eichstädt H; Christe W; Langer M; Felix R
    J Comput Assist Tomogr; 1989; 13(4):567-71. PubMed ID: 2787339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
    Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
    Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.